Sign in to view Alex’s full profile
or
New to LinkedIn? Join now
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
Sign in to view Alex’s full profile
or
New to LinkedIn? Join now
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
New York, New York, United States
Sign in to view Alex’s full profile
Alex can introduce you to 10+ people at Origin
or
New to LinkedIn? Join now
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
2K followers
500+ connections
Sign in to view Alex’s full profile
or
New to LinkedIn? Join now
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
View mutual connections with Alex
Alex can introduce you to 10+ people at Origin
or
New to LinkedIn? Join now
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
View mutual connections with Alex
or
New to LinkedIn? Join now
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
Sign in to view Alex’s full profile
or
New to LinkedIn? Join now
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
About
Welcome back
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
New to LinkedIn? Join now
Activity
2K followers
-
Alex Kramer posted thisThere's a pattern I keep seeing at practices that adopted an AI scribe early: the scribe becomes the finish line, when it was only ever supposed to be the on-ramp. Heidi (or Nabla, or Suki, etc.) listens to the visit and produces a clean transcript. Genuinely useful. Clinicians love it. And then the workflow looks like this: transcript, copy into Claude or ChatGPT to draft a care plan, paste into a Google Doc, export to PDF, send to the patient portal. Four manual steps, every visit, for a workflow that should take zero. The scribe didn't close the loop. It just moved the bottleneck one step downstream, and made it more visible, because now the copy-paste is the only manual step left in an otherwise automated visit. The practices that adopted a scribe first are, ironically, the ones most ready to fix this. They've already proven the team is comfortable with AI in the clinical workflow. The scribe was the trust-building step, not the destination. I built that next step directly: a care plan generator that fires the moment the clinical note locks and reads straight from it, no copy-paste, no separate tool. It lands in draft mode first, so the provider reviews it before anything reaches the patient, then one click sends it to the portal. Same information, same trust boundary, one less place for anything to get lost in translation. If your AI scribe made visits faster but your post-visit workflow didn't change, you didn't get the automation. You got a better dictation tool.
-
Alex Kramer posted thisBeen heads-down building the last few months - the good kind of busy, the kind where quiet on LinkedIn is a sign of progress. I'm back online and ready to bring some of it out from behind the scenes, starting with one of my favorite lessons from that stretch. I shipped a clinical note scribe feature, watched clinicians actually use it, and then watched trust erode fast: the notes it generated were often wrong, and fixing them meant real hands-on rework for the clinical team, visit after visit. Version one ran on a premise that felt right: more structure, more rigor. Parse the whole visit (history, assessment, plan, vitals) into clean structured fields. It looked great in a demo. But every mismatch between what the AI produced and what the platform expected meant an engineering fix, not a quick edit, so wrong notes stayed wrong for days at a time. That sent me back to the workflows themselves, and the answer that came back was better than what I started with: only a few things actually need hard structure and an audit trail: medications, labs/imaging/orders, referrals, problem list. Everything else, the clinical team wanted as narrative, notes that read like a clinician wrote them. The fix wasn't "structure more carefully." It was "structure only what actually needs it." So the rebuild started there instead of in the AI logic: an admin panel where fields and templates are configurable by the team itself, each one paired with a plain-language description of what to parse for and examples of what good output looks like, plus a way to flag intake questions that should just prefill straight from the form, no AI interpretation needed. The lesson I'm carrying forward: more structured data isn't automatically better clinical product. The right amount of structure is set by what needs proving, not by what's technically possible to parse. Getting that right made the product simpler, and the team happier with it. Next week: what changed once the review flow caught up to that same idea.
-
Alex Kramer posted thisFive months ago a client came to me with a problem I've seen before: strong brand, specialized clinical model, and a platform that couldn't keep up. Fragmented tools, performance issues, providers jumping between three systems to complete a single visit, critical workflows going offline. Sound familiar? They knew something had to change, and had big aspirations to deliver on their brand promise. They didn't know what it would cost to fix it. Here's where we landed: a fully custom provider and patient experience, built on Canvas Medical, delivered in two months(!) after a focused discovery sprint to make sure we were building the right thing. I built the core of it myself using the Claude Code studio on top of the Canvas API. The most fun was that this build was truly end-to-end: requirements gathering, systems and feature design, operational workflow design, feature development, testing, training, go-live. No engineering team. They're saving hundreds of thousands in platform costs and now have a product that actually fits how they practice. And they won't need to hire engineering for quite some time; I can stay on fractional to maintain and extend it as they grow. This engagement couldn't have existed a year ago. Not because Canvas didn't exist. Because a fractional PM who can take something from discovery to deployed — largely solo in two months — wasn't really possible before the current generation of AI tooling changed what one person can do. The founders who are winning right now aren't necessarily the ones with the biggest engineering teams. They're the ones making the right foundational decisions and finding people who can execute across the whole stack.
-
Alex Kramer shared thisShout out to Bunkerhill Health and Out-Of-Pocket for hosting last night’s rooftop health tech hang! Always great to trade notes with other folks on what we’re seeing in the space, how our product design decisions are upended by AI, and also where to draw the line on clinical decision-making. Our trivia team also did okay!
-
Alex Kramer posted thisMost healthcare product thinking runs through two lenses: what the patient experiences, and what the provider experiences. Roadmaps and design reviews optimize for one or the other. A third lens gets skipped almost every time: whoever has to operate and maintain the thing after it ships. Call it clinical ops, call it the admin: the person who has to update a rule or fix a workflow six months from now without an engineer in the room. That's always mattered, but it's urgent now. Claude Code makes it possible to build custom interfaces, configs, and business logic almost as fast as you can describe them. More of that logic is quietly moving from vendor config screens into code only an engineer (..or Claude) can read. Patient and provider lenses tell you if a feature should exist. The ops lens tells you if it survives contact with reality. Whether someone without a codebase can see what the logic does, change it, or turn it off. Skip that, and you've shipped a liability with a UI. The fix: treat the third lens as a design requirement, not an afterthought. Build the admin surface alongside the feature, not after someone gets stuck. Who owns that on your team right now?
-
Alex Kramer shared thisProud to be part of this one! Great piece from Nick Kavassalis and the team at Origin on what's possible when a lean team builds instead of buys. My part of it: Origin's clinicians had outcomes data: engagement stats, progress tracking, severity thresholds. It existed but wasn't accessible during patient visits. The "buy" option runs $250-400 per provider per year, which adds up fast across their 110+ providers. I built it instead: a Chrome extension on top of their EMR, done in six weeks for a few hundred dollars in Claude tokens. This is part of a bigger shift in what a product advisor can deliver now — less roadmap decks, more shipped product. Great to see it in action with this team.Alex Kramer shared this"Technology has been democratized. A small, passionate team can roll something out in weeks, not months. For the first time, we can incorporate the slight improvements and feature requests that came up time and time again. It's enabled us to build at a speed and cost that simply wasn't possible before." Learn about what our team is building in Nick Kavassalis's latest article. Special thanks to Alex Kramer and Angela Dobinsky for their input and contributions!How We're Building Our Way to Better Clinical CareHow We're Building Our Way to Better Clinical CareOrigin
-
Alex Kramer posted thisA few years ago, I led an evaluation of 14 EHRs before we chose one. Here's what I wish I'd known going in. The number that matters most isn't the licensing fee. It's the engineering tax; the hours per sprint your team will spend maintaining the integration instead of building product. We built a scorecard. Clinical workflow fit, API flexibility, billing compatibility, support responsiveness, and cost, but also: how much custom front-end work will this require? What's the migration risk if we outgrow it? We selected Healthie. We ran the full cutover across 12 clinics and nationwide telehealth in a single weekend: zero business downtime, ahead of our own best-case timeline. The old platform's licensing fee was never the real cost. The maintenance tax was — the engineering hours it consumed every sprint. Healthie eliminated both: a few hundred thousand dollars a year in direct platform costs, and a team that could finally get back to shipping product instead of babysitting an integration. With AI tooling now, the speed delta between a good and bad architecture decision is larger than it's ever been. The evaluation methodology is the part most teams skip because they don't have a template for it. Full scorecard at https://lnkd.in/ggPeBYBK
-
Alex Kramer posted thisI built a clinical-facing product in weeks. Patient engagement tracking, outcomes measurement, program building. Solo, with Claude Code. Technically ready to ship. Then I was asked to hold. Not because of a bug. Not because of scope. Because deploying it would require serious clinician training, and rushing that would kill adoption before it started. A few more weeks of prep would make the difference between a tool that actually changes how the team practices and one that sits unused in a tab. So the product sat, ready, while we prepared the humans. I used the time well, testing, beta users, feedback cycles. But it clarified something: AI has widened the gap between "technically ready" and "organizationally ready." The build side is faster. The human side isn't. Clinicians adopting a new workflow requiring behavior to actually change, build new habits, trust a new tool - moves at roughly the same pace it always has. That gap is new, and most early-stage teams don't have a name for it yet. The instinct when you can build fast is to ship fast. But at a clinical practice, you're not just releasing software. You're asking trained professionals to change how they work. That has its own timeline, and it doesn't compress. Ship-ready and adoption-ready are two different milestones. The second one is the one that matters.
-
Alex Kramer posted thisThe most diagnostic question I ask in any discovery conversation: "What do you copy and paste?" Every instance is a missing integration or a tool that doesn't do what the team needs. Staff know exactly where the friction is. Leadership often doesn't. What I find at almost every practice I work with: → Intake forms → EHR (field by field, manually) → AI scribe output → EHR chart note (copy-paste, every visit) → EHR data → care plan document (manually assembled) → Care plan → patient portal (emailed as a PDF) Ambient scribes are collapsing the documentation step — but that second arrow, scribe output → EHR, is still copy-paste at most practices because the integration isn't there. AI surfaced the bottleneck by removing the step before it. And that scribe isn't free. Standalone tools run at least ~$70/provider/month. At 10 providers that's $700/month. At 50 it's $3,500. It scales directly with growth, which means the architecture question gets more expensive the longer you wait to ask it. The options aren't obvious: your EHR may already include a native scribe (Healthie Scribe, athenaAmbient, Epic's AI scribe). Clinician satisfaction with the current tool might make switching painful enough to keep it. Or the cost of replacing it may be lower than you think once you run the math. But you have to run the math — most practices haven't. Every instance of copy-paste points at a decision that was never made. What did AI expose when it took away the step before the copy-paste?
-
Alex Kramer reacted on thisAlex Kramer reacted on this🚀 We’re growing at Mavida Health! As we continue expanding our mission to provide specialized, accessible mental healthcare for women throughout every stage of life, we’re excited to grow our team across several markets. We’re currently hiring: ✨ Business Development Associate – New Jersey ✨ Business Development – Southern California ✨ Business Development – Northern California ✨ Psychiatric Mental Health Nurse Practitioners (PMHNPs) – NY, NJ & CA ✨ Licensed Mental Health Therapists – NY, NJ & CA At Mavida Health, we’re building a team dedicated to transforming women’s mental healthcare through compassionate, specialized care across life’s many transitions. Interested in joining us? Explore our current openings and apply here: https://lnkd.in/gWdPE-We Know someone who would be a great fit? Share this post with your network! 💜 #MavidaHealth #NowHiring #WomensMentalHealth #MentalHealthCareers #HealthcareJobs #PMHNP #TherapistJobs #BusinessDevelopmentMavida Health | Online women's mental health therapy and prescribingMavida Health | Online women's mental health therapy and prescribing
-
Alex Kramer reacted on thisAlex Kramer reacted on thisMidi Health is taking women’s health to the next level! Midi Health is officially making its national retail debut at Ulta Beauty, bringing its clinician-formulated, science-backed supplement line to stores nationwide and online! For too long, women navigating perimenopause, menopause, and midlife health shifts have been left to decode crowded, confusing supplement aisles on their own. Midi is changing that trajectory by meeting millions of women right where they shop. From targeted cortisol support to brain clarity formulas, Midi's line is built on clinical insights from hundreds of thousands of patient visits delivering real efficacy, safety, and care tailored to women’s midlife biology. What makes this milestone especially meaningful is the opportunity to bring women’s health into everyday spaces connecting women with products designed around the biological changes that can occur during perimenopause and menopause, while complementing individualized clinical care. Congratulations to Joanna Strober and the entire Midi Health team on this exciting next chapter!
-
Alex Kramer reacted on thisAlex Kramer reacted on thisA personal update: after nearly eight years, I've decided to close this chapter at Willow, and today is my last day as CEO. When I joined the company in 2019, we had transformative wearable pump technology and a big ambition: to reinvent the breast pump category and make life better for new moms. Today, the wearable category we pioneered represents the majority of pumps sold, and millions of women are now pumping with more freedom, confidence and control. In the last few years, we've expanded our products to support moms across breastfeeding and postpartum needs, and with our acquisition of Elvie last year, we've grown into a global platform for maternal wellbeing with an exciting roadmap ahead. I'm proud of those milestones, but what I'll carry with me most is the impact we've had on the women we serve and the culture of this team, who pour their hearts into a mission that matters, united by a fierce belief that moms are worth fighting for. After many months of succession planning with our board, I'm thrilled to hand the reins to Carolin Archibald, Willow’s next CEO. Carolin knows this category deeply, cares about it personally, and leads generously. Willow could not be in better hands. Thank you to all of Willow’s investors, partners and champions, and to every mom who has trusted us with her feeding journey. Leading Willow has been the privilege of my career. I’ll stay connected as an advisor and remain a passionate advocate for women’s health. And I will forever be cheering this team on. ❤️
-
Alex Kramer reacted on thisAlex Kramer reacted on thisVery excited to announce some big news! Elmhouse Learning, an Outsmart subsidiary, has acquired Elmbridge University. I’m thrilled to now serve as Elmbridge University’s Executive Chairman. It’s a pivotal time to innovate in higher ed. The need and the opportunity are tremendous. More in the comments.
-
Alex Kramer reacted on thisAI Charting within Healthie has gotten a whole lot more powerful. We see millions of minutes flow through Scribe each week, and this is now supplanted by a broader suite of solutions that follow a session from beginning to end. Specifically: ✅ Scribe: Chart Notes drafted within your specific template, per Appointment Type ✅ Encounter Summaries: Automatically generated a concise clinical summary upon the note being locked ✅ Scribe Tasks: Follow-up tasks drafted from session transcript, commonly used for referrals, lab orders, care plan assignments ✅ Chart Summaries: Key insights and Patient Synopsis generated pre-session within Patient Profile; updates in real-time based on new information presented in Chart Note [in Beta, reach out to sign up] Link to learn more in comments!
-
Alex Kramer liked thisAlex Kramer liked thisSchool was closed today for a professional development day, but work… was still work. 🥴 (truth be told… I forgot to request it off!) My son did art beside me before a meeting and proudly showed it to my coworkers. When I started to apologize, the response was, “No need to apologize.” Later, we took a clarity break and went for a walk. We looked for grasshoppers, stopped at a patch of wildflowers, and noticed the light coming through the trees. This is what workplace flexibility looks like to me. It’s the room to care for your child when school and work schedules don’t align, and coworkers who make that room feel normal. That kind of support matters to parents and families. Today, it meant I could be present for my work and for my son 🫶 Let’s make this the new normal!!
-
Alex Kramer liked thisAlex Kramer liked thisToday EliseAI is announcing a $350 million funding round at a $4 billion valuation, led by Andreessen Horowitz (a16z) and Bessemer Venture Partners, with participation from Ontario Teachers' Pension Plan, Sapphire Ventures, and Navitas Capital. Over the past few years, Elise showed that AI can change the economics of a foundational industry. 1 in 5 multifamily apartments in the US run on our products. Those units see 2pp higher occupancy. And their operators see up to 20% higher NOI. It points to a larger truth about the intelligence age: this extraordinary technology can raise the standard of ordinary life for everyone. But for it to do this, someone has to do the work of building AI for the hardest, most important industries in the world. So that, as intelligence gets cheaper, life does too. And the benefits of AI reach everyone. This round gives us the resources to go deeper and work faster. I wrote about everything we’ll accomplish in housing and why we’re bringing AI to essential services industries. Thank you to our investors, our customers, and our team. There’s so much to do, and I’m excited to keep building together.Intelligence is getting cheaper. Life should too.Intelligence is getting cheaper. Life should too.Minna Song
-
Alex Kramer liked thisAlex Kramer liked thisBHT really does feel like home! 💜 A few highlights from the past week: - Got to catch up with some of the people I’ve been lucky enough to work with: Emma Sugerman, Dawn Androphy, Connor Gordon, Amy Brandli, Alexander Mueller, Aaron Reichlin, MD, Brian Yam - Spent two weeks traveling with my amazing cousin (and coworker!) Paula Pereira and got to join Macky Rocabado Gay on her first Light-itt-it trip. Both absolutely killing it! - Had a karaoke moment with Erez Lirov 🎤 - Got to see some Nashville bands that absolutely blew me away! 🤠 Reconnected with so many amazing people: Micah Friedland, Tom Kim, Dr. Ashish Mandavia, MD, Carmine Di Maro, Nick Neral, Jessica Holton, Erica Jain, Caseley B Pinto, Greg Milnarik, Noah Goldfarb, Julia Morgan Knight, Derek Strauss, Edmond Coku, Ignacio (Iggy) Handal, Damayanti Dipayana, Jaime Calderon Goff, and met so many new people doing exciting work who I’m hoping to add to my “friends of BHT” list :) Mike Lifshotz, Rich Sneider, Douglas R. Polster, Ph.D., Alexander Alvarado, Psy.D., AK Azaiez, Danny Gladden, LCSW, MBA, Guedis Cardenasl Humberto Buniotto, and so many more!! Already looking forward to the next one! #BHT2026 Behavioral Health Tech
Experience & Education
-
ARK Foundry
*******
-
******
*******
-
******* * *******
********* ******* ******** ******* ********** ******
-
******* **********
******** ** **** **** *** ***** *********** ******* undefined
-
*** ***** ******* ********** * ***** ******** ******
****** ** ******** ************** ***** undefined
-
View Alex’s full experience
See their title, tenure and more.
Welcome back
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
New to LinkedIn? Join now
or
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
Licenses & Certifications
Honors & Awards
-
Cum Laude
Cornell University, Information Science Department
Awarded Cum Laude for research in Information Science.
Languages
-
English
Native or bilingual proficiency
-
Spanish
Professional working proficiency
View Alex’s full profile
-
See who you know in common
-
Get introduced
-
Contact Alex directly
Other similar profiles
-
Mike Doustan, CSPO, CSM, PMP, PMI-ACP, SSM
Mike Doustan, CSPO, CSM, PMP, PMI-ACP, SSM
Montefiore Information Technology
7K followersNew York, NY
Explore more posts
-
Rodrigo Hütt
iThriveMD • 10K followers
Most growth-stage companies don’t need a bigger data team or more tools. They need better questions and clear definitions. That was one of the clearest takeaways from my conversation with Ryan Koonce on Health Tech Builders. What I see (and Ryan sees) over and over: Teams argue about numbers because they never agreed on definitions Leaders ask dozens of analytics questions, but prioritize none Data teams become translators and bottlenecks Decision velocity slows—even as dashboards multiply Ryan put it simply: “Data isn’t just the number. It’s the definition behind the number.” And this is the part many companies miss: If you can’t clearly answer what decision this data is meant to inform, then more tools, more reports, and more analysts won’t help. What actually works: Leaders align on a small set of business-critical questions Metrics are defined once and owned at the exec level Clean data foundations make answers accessible And increasingly, executives explore data directly—often with AI Clarity first. Data second. That’s how analytics turns into leverage instead of noise. #Leadership #DataStrategy #ScalingCompanies
9
1 Comment -
Natalie Freels
Mayo Clinic • 4K followers
Your HealthTech product is solid, but you aren’t getting traction. Pilot stalls Failed to scale Uninterested clinicians Ghosted by administrators Founders, why why oh why is this happening to you? If you are building in HealthTech, You have to build something you know will either - fit seamlessly into the current workflow OR - disrupts a current broken workflow and builds it back with true effectiveness And you can only do this if you talk to clinicians Boots on the ground Taking care of patients Doing the admin tasks In the trenches Not their bosses Not their C-suite Not the crusty old RN or MD MBA who hasn’t done a set of vitals in 23 years (sorry) Not your college roommate or golfing buddy. It doesn’t have to be hard. It doesn’t have to break your budget. But you desperately need to validate your implementation to communicate value and drive adoption.
24
15 Comments -
Benjamin Schwartz, MD, MBA
Good Bones Medical Advisory… • 39K followers
Hot take Tuesday: regulation and policy, not tech, will have the biggest impact on healthcare over the next 5 years. Don't get me wrong, tech will play a role, just not the massive, disruptive one everyone is assuming. The counterpoint to the general AI doomerism that's been going around is that industries are slow to change, protectionist, and survivalist. We still lack real-world evidence that efficiency improvements, productivity gains, and cost savings are meaningful. Those counterfactuals may be truer in healthcare than any other field. Everyone realizes they need a tech strategy, but few have the time to develop and implement one. The more immediate threats are declining reimbursements, mandatory (and complicated) CMS payment models, staffing shortages, site neutral payments, site of service shifts, rising overhead, market competition, transparency rules, etc. These things are happening now and have tangible impact on the bottom line. The appetite for a potentially disruptive tech implementation that *might* lead to ROI at some undefined time point is low. Regulatory changes and technology implementation are not mutually exclusive. In fact, they're going to depend on each other for success going forward. But too much emphasis is being placed on the latter and not enough on the former.
20
3 Comments -
Luminary Group
48K followers
🚨 MIDI HEALTH HITS $1 BILLION VALUATION 🚨 Midi Health has become the latest women’s health unicorn, reaching a $1 billion valuation following a $100 million Series D round led by Goodwater Capital💰. Founded by Joanna Strober, Midi began as a telehealth platform focused on menopause care and is now expanding into weight loss and branded supplements. Crucially, the ambition is clear: to build the biggest consumer brand in women’s health 🌍 For those of us in life sciences executive search, this moment matters 👇 It reflects a broader shift in the market: • Women’s health moving from underserved to investable at scale 📈 • Consumer-first healthcare brands becoming credible category leaders 🏆 • Founder-led vision shaping businesses built for long-term impact, not quick exits 🚀 Midi has now raised $250 million in total funding. Strober has been clear she is not looking to sell. Instead, she is focused on building something truly large and, in doing so, inspiring more women to build and lead ambitious companies ✨👩💼 As investors, boards and leadership teams look ahead, this is a powerful reminder that representation at the top shapes entire markets 💡 #WomensHealth #FemaleFounders #Leadership #LifeSciences #HealthTech #ConsumerHealth #ExecutiveSearch #WomenInLeadership #LuminaryGroup
10
-
Doug Hayes
Marblehead & Company • 9K followers
Three incredible days at #JPM2026. Same conversation with 10+ health system execs: "We're building our AI strategy. Evaluating vendors. Need to pick the right partners." This sounds familiar. 2009-2012: The EHR decision. After the HITECH Act, health systems spent 18-24 months evaluating Epic vs. Cerner. Consultants. Committees. RFPs. Multi-year implementations. The logic made sense: EHRs were monolithic platforms with huge switching costs. You had to get it right. 2025: The AI decision. I'm watching health systems do the same thing. "AI steering committees." "Strategic AI partner" RFPs. Trying to pick winners. But there's a critical difference: EHRs were a single, massive platform decision. AI in healthcare is dozens of different problems that need dozens of different solutions. Here's what health systems are missing: They're looking for "the AI vendor" when they should be building "an AI portfolio." There's no single AI platform that solves: → Documentation burden (ambient notes) → Radiology throughput (workflow optimization) → Clinical trials matching → Revenue cycle optimization (across specialties) → Clinical decision support These are different problems. Different technologies. Different vendors. Different timelines. Some need FDA clearance and 24-month validations. Some can pilot in 90 days. Some integrate with Epic. Some replace parts of Epic. You can't solve all of these with one "strategic AI partnership”....no matter that Anthropic is saying right now. <ducks> The AI landscape is evolving too fast for monogamous vendor relationships. 6 months ago: GPT-4 for clinical documentation. Today: Ambient listening, agentic workflows, multimodal imaging analysis. 6 months from now: Something else entirely. That's why you need exposure across the whole landscape—not a bet on one vendor. The mistake I see health systems making: Approach 1: "Strategic Partner" Strategy Pick one AI vendor → Enterprise deal → 3-year commitment → Hope they solve everything Result: You're locked in. Technology moves on. You're stuck in vendor negotiations while competitors move faster. Approach 2: "Portfolio Strategy" Deploy capital across multiple companies → Take equity → Co-develop solutions → Maintain optionality Result: You capture upside. You shape products. You're first to new capabilities. You have relationships across the ecosystem. After 20 years building innovation platforms at JPMorgan, Mousse Partners, Blueprint Health, Junto Health, Atlantic Health: In fast-moving markets, portfolio strategies beat single-vendor bets. Healthcare AI is moving fast. The question isn't "Which AI vendor should we pick?" The question is: "How do we build an AI portfolio that gives us the most optionality" If you're thinking about this, let's talk. 📩 douglas.m.hayes@gmail.com ☎️ 215-620-2032 #healthcareAI #digitalhealth #venturecapital #innovation
293
25 Comments -
Dr Alice McGee
Flo Health Inc. • 16K followers
Your title sounds senior. But is it in reality? In healthtech, clinicians are given impressive titles: → Clinical Lead. → Director, Clinical Product → Head of Clinical Operations. It feels like progression. You’re in meetings. You’re quoted externally. You’re introduced as “the clinical voice.” But when Product wants to ship… Can you block release? If you can’t stop the decision, you don’t own the decision. Don't confuse authority with visibility. Authority is: → Defined decision rights → Control over thresholds → Ability to veto → Ownership of downside risk If the initiative fails, whose name is attached? If harm occurs, who carries it? That is where power sits. Before accepting a role, clarify: → Do I have formal sign-off? → Who can override me? → Where does escalation go? → Is this advisory or executive? ❌ “I represent clinical perspective.” ✅ “I hold release approval subject to defined safety criteria.” Early career: optimise for proximity to decisions. Mid career: negotiate partial ownership. Senior career: formalise governance authority. ---- 📌 Save this before accepting your next “senior” title ♻️ Repost if this clarified something uncomfortable 🙋♀️ Follow Dr Alice McGee for decision frameworks in healthtech leadership
70
16 Comments -
Mario Amaro, MD
Cline • 15K followers
Hot take: betting or investing in any niche EHR right now (e.g. AI-native EHR for X clinical specialist or X vertical like Longevity) when AI code development exists and only continues to get better with each new model release has to be dumbest pre-AI SaaS era thing an investor can do. Here's why ⤵️ The EHR market is essentially split into 5 categories: #1. Outpatient EHR-enabled private practice (doctor or clinical owned) #2. Outpatient tech-enabled practice (PE, VC, family office owned) #3. Outpatient tech-enabled practice (MBA or bootstrapped owned) #4. Startup enterprise (PE or VC backed) #5. Inpatient hospital VC backed EHRs primarily make their money selling to #2-4, with the Epic's of the world taking most if not all of 5. For #1 there really isn't any true TAM since it's difficult to acquire this customer even when giving the EHR product away for free. But here's what these EHRs are not telling you and why they're all racing to update their API docs. They hope that #2-4 will continue to use their solutions to build with AI vs exiting and vibe coding their own in-house solutions. So when you hear them say their EHR product is safe from AI, that's not true. Right now the Epics of the world are safe but it's customers in categories 1-4 who will 100% vibe code their own solutions. #VibeWithCline #LetDoctorsVibe
24
21 Comments -
Inna Sheyn
Aramis Advisors • 5K followers
𝗗𝘂𝗼𝘀 𝗥𝗮𝗶𝘀𝗲𝘀 $𝟭𝟯𝟬𝗠 𝘁𝗼 𝗔𝗱𝘃𝗮𝗻𝗰𝗲 𝗔𝗜 𝗳𝗼𝗿 𝗦𝗲𝗻𝗶𝗼𝗿 𝗛𝗲𝗮𝗹𝘁𝗵 𝗡𝗮𝘃𝗶𝗴𝗮𝘁𝗶𝗼𝗻 Duos has secured $130M in growth equity led by FTV Capital and Forerunner Ventures to expand its AI platform and partnerships across Medicare Advantage, Medicaid, and ACA plans. The funding will enhance Duos’ Chat 2.0 AI, which uses Retrieval Augmented Generation to deliver multilingual, CMS-compliant, and personalized guidance for seniors while combining automation with a human touch. The company already serves more than 15M Medicare Advantage members through collaborations with Humana (HUM), Magellan Healthcare, and Geisinger Health Plan. The investment underscores AI’s growing role in the $9T longevity economy. Duos helps older adults live independently by connecting them to health plan benefits, community programs, and support services that improve access, coordination, and confidence in managing their care. https://lnkd.in/eW4sYSNA
-
Rich G Kenny
American Nurses Association • 5K followers
If you are an EMR without an open/"public" API strategy... because you've arguably been following the Epic playbook for years... well, that playbook just changed. (I need to clarify that said strategy should not require doubling the price either in order for clients to "pay to play") Health tech of the future is (finally) going to look very different than it does today. I have a vision for this. For the first time, I can actually say that I think Epic might be getting on board with it ;)
12
5 Comments -
Gary M. Austin
4K followers
Former Drawbridge Health CEO Launches Manifold Health AI at JPM to Build the First Digital Health Index Twin for Chronic Disease. SAN FRANCISCO, Jan. 13, 2026 /PRNewswire/ -- Manifold Health AI today announced its launch at JPM Healthcare Week and the GMT MedTech Symposium, unveiling a first-to-market platform that combines a novel, precision-designed blood test with an AI-driven Digital Health Index Twin to translate biological data into financial risk intelligence for healthcare infrastructure. The announcement was delivered by Manifold's Founder and CEO, Jerome Scelza. This will fundamentally change health risk management, improve health outcomes, and make healthcare affordable again. For the complete press release: https://lnkd.in/e9NsnRiT Message me if you would like to know more!
5
Explore top content on LinkedIn
Find curated posts and insights for relevant topics all in one place.
View top content